ClinicalNews

Shortage continues

EpiPen
New notification of 'tight supply' of EpiPens, as stock shortages continue The TGA has renewed its advice about continuing issues with the supply of EpiPens in Australia. In the latest notification, issued on Monday, the TGA says: "Alphapharm Pty Ltd (trading as Mylan Australia), has confirmed that, while supply to wholesalers is increasing, there continues

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous ‘Taking shortcuts with your health is simply not worth it.’
Next How new standards could double hypertension numbers

Related Posts